AbbVie | ABBV - Loan Capital

Stock Price
218.97
Daily Change
1.86 0.86%
Monthly
-2.22%
Yearly
13.47%
Q1 Forecast
216.14

AbbVie reported $62.97B in Loan Capital for its fiscal quarter ending in September of 2025.





Loan Capital Change Date
AbbVie USD 62.97B 12M Sep/2025
Abbott USD 11.6B 1.33B Sep/2025
ALKERMES USD 285.82M 639K Sep/2024
Amgen USD 52.43B 1.33B Sep/2025
AstraZeneca USD 6.55B 19.43B Sep/2025
Biogen USD 6.29B 1.4M Sep/2025
BioMarin Pharmaceutical USD 596.66M 501K Sep/2025
Bristol-Myers Squibb USD 44.47B 1000K Sep/2025
Eisai JPY 134.75B 34.91B Sep/2025
Eli Lilly USD 40.87B 6.69B Sep/2025
Gilead Sciences USD 22.14B 5M Sep/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
J&J USD 39.41B 173M Sep/2025
Medtronic USD 26.18B 537M Jun/2025
Merck USD 39.97B 6B Sep/2025
Neurocrine Biosciences USD 169.5M 500K Mar/2023
Novartis USD 24.24B 174M Sep/2025
Pacira USD 376.72M 1.37M Sep/2025
Perrigo USD 3.61B 7.4M Sep/2025
Pfizer USD 57.41B 93M Sep/2025
Regeneron Pharmaceuticals USD 2.71B 720.4M Dec/2025
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 15.72B 2.45B Dec/2025
UCB EUR 2.82B 146M Jun/2025
Ultragenyx Pharmaceutical USD 782.75M 11.3M Jun/2025
United Therapeutics USD 100M 100M Jun/2024
Vertex Pharmaceuticals USD 111.4M 1.4M Mar/2025
Zoetis USD 7.07B 1.84B Sep/2025